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Acute skeletal muscle wasting
and dysfunction predict physical disability
at hospital discharge in patients with critical
illness
Kirby P. Mayer1,2* , Melissa L. Thompson Bastin3, Ashley A. Montgomery‑Yates4, Amy M. Pastva5,
Esther E. Dupont‑Versteegden1,2, Selina M. Parry6† and Peter E. Morris4†

Abstract
Background: Patients surviving critical illness develop muscle weakness and impairments in physical function; how‑
ever, the relationship between early skeletal muscle alterations and physical function at hospital discharge remains
unclear. The primary purpose of this study was to determine whether changes in muscle size, strength and power
assessed in the intensive care unit (ICU) predict physical function at hospital discharge.
Methods: Study design is a single-center, prospective, observational study in patients admitted to the medicine or
cardiothoracic ICU with diagnosis of sepsis or acute respiratory failure. Rectus femoris (RF) and tibialis anterior (TA)
muscle ultrasound images were obtained day one of ICU admission, repeated serially and assessed for muscle crosssectional area (CSA), layer thickness (mT) and echointensity (EI). Muscle strength, as measured by Medical Research
Council-sum score, and muscle power (lower-extremity leg press) were assessed prior to ICU discharge. Physical func‑
tion was assessed with performance on 5-times sit-to-stand (5STS) at hospital discharge.
Results: Forty-one patients with median age of 61 years (IQR 55–68), 56% male and sequential organ failure assess‑
ment score of 8.1 ± 4.8 were enrolled. RF muscle CSA decreased significantly a median percent change of 18.5% from
day 1 to 7 (F = 26.6, p = 0.0253). RF EI increased at a mean percent change of 10.5 ± 21% in the first 7 days (F = 3.28,
p = 0.081). At hospital discharge 25.7% of patients (9/35) met criteria for ICU-acquired weakness. Change in RF EI in
first 7 days of ICU admission and muscle power measured prior to ICU were strong predictors of ICU-AW at hospital
discharge (AUC = 0.912). Muscle power at ICU discharge, age and ICU length of stay were predictive of performance
on 5STS at hospital discharge.
Conclusion: ICU-assessed muscle alterations, specifically RF EI and muscle power, are predictors of diagnosis of ICUAW and physical function assessed by 5x-STS at hospital discharge in patients surviving critical illness.
Keywords: Critical illness, Muscle wasting, ICU-acquired weakness, Physical function, Acute respiratory failure, Sepsis,
Muscle atrophy, Muscle power
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Background
Patients surviving critical illness have significant skeletal
muscle wasting and dysfunction, including weakness and
atrophy [1, 2]. Up to two-thirds of patients admitted for
critical illness will be diagnosed with intensive care unitacquired weakness (ICU-AW) [3], leading to deficits in
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physical function [4, 5]. As a result, survivors have longterm physical disability leading to difficulty performing
activities of daily living (ADL), such as standing up from
a chair, and deficits in these basic ADLs are highly associated with poor health related-quality of life (HRQoL)
[6, 7]. Observational and single-center randomized controlled trials demonstrate that physical rehabilitation
provided in the ICU may positively influence short- and
long-term patient outcomes, including greater muscle
strength at ICU discharge, reduced mechanical ventilation duration and improved HRQoL [8–11]. Moreover,
clinical practice guidelines recommend physical rehabilitation for mitigating the detrimental effects of immobilization that occur during critical illness [12, 13]. However,
recent ICU-based physical rehabilitation randomized
controlled trials (RCTs) fail to demonstrate robust immediate or long-term functional benefits [11, 14–18]. One
potential explanation for these results is subject heterogeneity [19]. Also, rehabilitation trials rarely implement
or stratify interventions based on muscular dysfunction
leading to “one-size fits-all” interventions.
Muscle strength and muscle power are vital components of muscular function. Muscle power is differentiated from muscle strength in that power accounts for
velocity (distance/time) of force production, while muscle strength is the ability to generate maximal muscle
force only [20]. Muscle power is crucial for daily activities that require velocity to overcome distance or gravity,
such as standing up from a chair or from a toilet [21, 22].
However, muscle power is not a current focus in ICU or
hospital rehabilitation. Assessment of muscle power is
novel in this population, and deficits in power suffered
during critical illness may help explain persistence of
physical function impairments.
Early classification of muscle wasting and dysfunction,
including the degree of deficit, is important for appropriate allocation of rehabilitation interventions, but difficult
due to the heterogeneity and severity of acute critical
illness [23]. Muscle ultrasound has gained significant
traction as a tool to assess and track changes in skeletal
muscle potentially improving classification of patients
who may be at risk for muscular or physical impairments.
However, data surrounding muscle ultrasound are conflicting. A recent study demonstrated that muscle size
measured at day 7 of ICU admission was not predictive
of ICU-AW [24], while an observational study in a cohort
of 22 critically ill patients demonstrated that muscle size
and quality were associated with physical function at ICU
discharge [25]. Additionally, earlier and greater change
in muscle size measured by ultrasound was associated
with in-hospital mortality, mechanical ventilation (MV)
duration and ICU-AW [26]. Conflicting evidence may
be attributed to the heterogeneity in patient populations
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and potentially discrepancies in user approach leading
to variations in practice and human operator error [27].
Currently, there is a need to determine whether muscle
mass, quality and function assessed in ICU are related to
or predictive ICU-AW and physical function at hospital
discharge. The purpose of this study was to determine
whether muscle alterations assessed during an ICU stay
by changes in muscle size, quality, strength and power,
are associated with or predict diagnosis of ICU-AW and
physical function at hospital discharge.

Methods
Ethical considerations

This study was reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines and approved by the
Institutional Review Board at the University of Kentucky.
Research subjects or legally authorized representative
provided written informed consent before participating
in the study. Consent was obtained from a legally authorized representative for patients unable to give consent
due to sedation, mentation and/or consciousness, and reconsent was obtained once patient was awake, stable and
could provide informed consent themselves.
Study design

A prospective, longitudinal observational study was conducted with adult patients admitted to Medicine ICU
(MICU) or the Cardiothoracic ICU (CTICU) and enrollment occurred from November 15, 2018, to July 15, 2019.
Eligibility criteria were: 18 years of age or older with a
primary or secondary diagnosis of acute respiratory failure (ARF) or sepsis of any origin that were anticipated to
spend more than 3 days in the MICU/CTICU and survive the current hospitalization and enrolled within 48 h
of admission. In 2019, patients admitted to MICU had
a variety of admitting diagnoses with a mean sequential
organ failure assessment (SOFA) of 6.3 with mean ICU
length of stay (LOS) of 4.9 days and all-cause mortality
of 21% [28]. Patients in the CTICU have a similar acuity
level requiring critical care for postoperative cardiac and
thoracic surgery, as well as patients requiring extra-corporeal membrane oxygenation for any indication. Thus,
the inclusion criterion with diagnosis of ARF and sepsis
was utilized to set a minimum severity level to reduce
the heterogeneity given the MICU and CTICU have a
diverse patient population with range of severity of illness. Patients were excluded from enrollment if they had
baseline cognitive impairments, were non-ambulatory
prior to hospitalization, had a pre-existing neurologic
or neuromuscular disorder, new traumatic injury with
lower-extremity fracture, one or more amputations of
lower-extremity, were pregnant, admitted for substance
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abuse or were otherwise inappropriate for study procedures as determined by the primary attending physician. Patients with morbid obesity (body mass index
(BMI) > 45 kg/m2) were excluded to reduce distortion of
ultrasound images.
Study procedures
Muscle ultrasound

The right quadriceps femoris muscle and the right tibialis
anterior (TA) were assessed for muscle size and echointensity (EI) with the SonoSite IViz (FUJIFILM SonoSite
Inc. Bothell, WA) portable ultrasound with 8.5-MHz
linear transducer on ICU days 1, 3, 5 and 7. Ultrasound
device settings were kept constant for subjects across
time points with the same sonographer (KM, physical
therapist, PhD, > 4 years of muscle ultrasound experience)
acquiring all images [29]. The methods for image acquisition and analysis of quadriceps and TA were previously
reported [1, 30] and have good to excellent reliability [29,
31–33]. Minimal probe compression and depth of 5.9 cm
were utilized to obtain three images at all time points
of both muscles. Quadriceps femoris muscle imaged at
2/3 distance from anterior superior iliac spine (ASIS)
to superior patella border and TA muscle imaged at 1/3
distance from lateral tibial plateau to inferior border of
the lateral malleolus. Images were saved on the device
hard drive and transferred to computer for analysis using
ImageJ software (NIH, Bethesda, MD). The average value
of three consecutive images was used in analyses [25, 27].
Quadriceps femoris ultrasound images were analyzed
for quantification of rectus femoris (RF) muscle crosssectional area (CSA), RF muscle thickness (mT), quadriceps complex (QC) muscle thickness (rectus femoris plus
vastus intermedius thickness) and for muscle quality (EI)
[29]. TA muscle ultrasound images were analyzed for mT,
CSA and EI. The final analyses included two approaches:
CSA, mT and EI on ICU day one of admission to ICU
(baseline) and parameters as percentage change from
ICU day 1 to day 7.
Prior to volitional assessments, the patient had to
be oriented (determined as ability to complete 3 of 4
domains of name, birthday, location and date) and follow
simple commands by scoring ≥ 3/5 on DeJonghe criteria
[34].
Muscular strength, power and physical function

Muscle strength was assessed using three different techniques at ICU discharge and hospital discharge:
1 The Medical Research Council-sum score (MRCss) is a measure of global peripheral limb muscle
strength that is standard of care for diagnosing ICUAW with less than 48/60 denoting diagnosis [34–37].
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2 Muscle strength force production and the rate of
force development of the right knee extensors and
right ankle dorsiflexors were recorded using a handheld dynamometry (HHD) (Lafayette Manual Muscle Test System Model-01165, Lafayette Company,
Lafayette, IN) [38]. HHD to assess isometric muscle strength is reliable and correlated with the gold
standard of isokinetic dynamometry [38]. Knee
extension was measured in supine or semi-reclined
(head of bed < 30 degrees) position with 20 degrees
of knee flexion using a roll with dynamometer positioned proximal to the foot on the tibia [39]. Ankle
dorsiflexion was measured with the knee in ~ 5
degrees of flexion (small towel under the knee) and
supported on a hospital bed or leg rest with the ankle
in neutral with dynamometer positioned on the dorsum of the mid-foot. Patients unable to extend lower
limb or dorsiflexion foot against gravity (< 3/5 on
MRC-ss for knee extension and ankle dorsiflexion)
did not perform HHD. Patients participated in a minimum one practice repetition with therapist providing standardized verbal cues for activation, direction
and encouragement. The peak value of six second
contraction was recorded, and the average of three
repetitions was used in analyses with patients resting
a minimum of 30 s between repetitions.
3 Handgrip strength of dominant hand was assessed at
ICU discharge and hospital discharge using the Jamar
hydraulic dynamometer (Sammons Preston Rolyan,
Bolingbrook, IL, USA) with technique, position and
cues previously described [37, 40]. The average of the
peak values for three repetitions was utilized in the
analysis.
Muscle power was assessed at or prior to ICU discharge and again at hospital discharge with a linear
potentiometer (HUMAC-360, CSMi, Stoughton,
MA) to record the velocity and peak-velocity of a
unilateral lower-extremity press using a Shuttle MiniPress (Shuttle Systems, Bellingham, WA) while sitting in hospital bed or seated in hospital chair [41].
Subjects performed three repetitions of the leg press
at two pre-determined levels of resistance, 2 lbs and
10% of bodyweight. Patients were permitted to perform three repetitions for familiarization prior to formal testing.
Physical functional outcomes The primary physical function outcome of interest was performance
of 5-times sit-to-stand test (5 × STS) at hospital
discharge since it is a fundamental component of
mobility and an independent measure of muscle
strength and power [42]. The short performance
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physical battery (SPPB) [43, 44], six-minute walk
distance (6MWD) [45, 46] and clinical frailty scale
(CFS) were assessed at hospital discharge. The CFS
is validated tool assessing frailty based on mobility
status, cognitive and physical function, and levels of
independence [47].
Standard rehabilitation and nutrition care Patients
admitted to MICU/CTICU receive physical therapy
and occupational therapy as standard of care initiated by order at the discretion of the primary attending. Physical and occupational therapy sessions
typically occur 2–5 times per week lasting ~ 30 min
and initiated upon weaning of sedation with MICU
and CTICU medical teams attempting to follow the
ICU Liberation Bundle (A-F) [13]. Patients requiring sedatives and not appropriate for active mobilization receive passive range of motion at minimum
three times delivered daily by a mobility technician
or nursing staff. Active mobilization is initiated by
the interdisciplinary team as soon as sedation is
weaned and hemodynamic stability is reached per
prior recommendations [48]. The Physical Function in the ICU Test (PFIT-s) was performed by staff
physical therapists according to routine care which
includes performing the test upon initial evaluation
in the ICU [49, 50]. Nutritional practice in our institution aligns with the SCCM/ASPEN guidelines for
critically ill adults [51]. Our nutrition support service assesses all ICU patients and provides an individualized enteral nutrition plan within 24 to 48 h
of ICU admission for patients without volitional
intake. Enteral and volitional daily nutritional goals
are based on 25 kilocal/kilogram per day for caloric
intake (kilocal) and 1.2–2.5 g/kilogram per day of
protein [51].
Clinical variables Baseline demographics (age, sex,
BMI), Charlson comorbidity index (CCI) and critical illness data including ICU admission diagnosis,
sequential organ failure assessment (SOFA), hours
of mechanical ventilation (MV), ICU and hospital
length of stay (LOS), time to first rehabilitation session, number of rehabilitation sessions, sedation (yes/
no), use of inotropes and vasopressors (yes/no) and
mortality (defined as in-hospital mortality plus transfer to inpatient hospice) were assessed.

Statistical considerations

Sample size A priori sample size calculation was not
performed. The sample size was pragmatically based on
8-month time frame as well as previously published literature [1, 25].
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Statistical analysis

Data were assessed using descriptive statistics including
mean and standard deviation (SD) or median and interquartile range (IQR), histograms and Shapiro–Wilk test
for normality. Ultrasound data were examined for change
over time using a linear mixed-model approach. The
relationships between muscle ultrasound parameters,
muscle power, muscle strength, demographics, clinical
and physical function data were assessed with Spearman
Rho tests. A multivariate logistic regression model was
created to assess the effects of independent variables on
development of ICU-AW at hospital discharge. Variables
identified for the model included baseline demographics
(age, sex, BMI) and other variables that are purported to
be associated with weakness including muscle size and
quality, severity of illness, ICU length of stay and muscle power. Stepwise backward regression at the 0.2 level
was used to minimize overfitting. Power assessment (10%
BW) at ICU discharge was forced into the model, as this
is our primary exploratory predictor variable. Using the
same approach, a multivariate linear regression was used
to assess the relationship between predictor variables
with dependent variable of 5-times sit-to-stand performance at hospital discharge. The models were tested for
assumptions of logistic and linear regression as appropriate. Multicollinearity was assessed using variance inflation factor; normality of errors was assessed with the IQR
test. We assessed model fit with the Hosmer–Lemeshow
and likelihood ratio tests. Heteroskedasticity of residuals
was assessed with the Breusch–Pagan/Cook–Weisberg
test, and standardized robust errors were used to adjust
for heteroskedasticity in the models as appropriate. All
other assumptions were met. Data were analyzed and visualized using GraphPad Prism 8.2 (GraphPad software,
San Diego, CA), and regression analyses were performed
using Stata (version 14.2, Stata Corp, College Station,
Texas, USA).

Results
Forty-eight patients admitted to MICU and CTICU with
median age of 61 (55–68), 56% (n = 27) males, and admission SOFA score of 8.1 ± 4.8 was enrolled in this study.
Seven patients were removed due to missing ultrasound
images at baseline due to assessor unavailable (n = 1) or
images available could not be analyzed due to poor quality (n = 6). Demographic and clinical data of the forty-one
patients included in the analyses are presented in Table 1.
The time to first ultrasound measurement was median
1.1 days (IQR 0.77–1.4) after ICU admission. Paired
ultrasound data were available for 35 patients on day
1 and day 7 of ICU admission, and 6 patients had missing images due to assessor unavailable (n = 2) or patient
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Table 1 Patient demographics and critical illness data
Parameter

(n = 41)

Age (years), median [IQR]

61 [55–68]

Male, n (%)

23 (56)

BMI (kg/m2), mean (SD)

29.6 (6.3)

Charlson comorbidity index, mean (SD)

5.5 (3.12)

Admitted to medical ICU, n (%)

30 (73)

Admitted to cardiothoracic ICU, n (%)

11 (27)

SOFA at ICU admission, mean (SD)

8.1 (4.8)

ICU LOS days, median [IQR]

8 [4]

Hospital LOS days, median [IQR]

11.2 [8–19]

MV, n (%)

30 (73)

MV, days, median [ IQR]a

3.4 [1–7.7]

CRRT, n (%)

5 (12)

CRRT, days, median [IQR]b

9.8 [6.9–10.1]

ECMO, n (%)

2 (5)

Sedation, n (%)

24 (59)

Sedation, days, median [IQR]c

2 [1–3.25]

Inotropes and pressor, n (%)

25 (61)

Inotropes and pressor, days, median [IQR]d

4 [2–7]

Neuromuscular blocker, n (%)e

2 (5)

Time to first ultrasound measures, days, median [IQR]

1.1 (0.7–1.4)

Time to initial physical therapy session, days, mean (SD)

2.6 (1.84)

Time to initial occupational therapy session, days, mean (SD)

3.2 (2.71)

Number of rehabilitation visits for entire hospital stay, median, [IQR]

6 [4—9.25]

In-hospital mortality, n (%)

5 (12)

IQR = interquartile range; ICU = intensive care unit; BMI = body mass index; SOFA = sequential organ failure assessment; LOS = length of stay; ICU = intensive care unit;
MV = mechanical ventilation; CRRT = continuous renal replacement therapy; ECMO = extra-corporeal membrane oxygenation;
a

b

MV duration reported in days as median [IQR] for patients (n = 30) that required MV

CRRT duration reported in days as median [IQR] for patients (n = 5) that required CRRT

c

Duration of sedation reported for patients that received at least one sedative defined as number of days receiving at least one dosage

d

Duration of inotrope and pressor for defined as the number of days a patient received at least one dosage

e

2 patients received long-term NMB (8 and 23 days, respectively, in addition 23 patients received a one-time 50 mg doses of rocuronium for intubation or surgical
procedure) (n = 23, 56%)

discharged prior to day 7 (n = 4), and thus, US data from
ICU day 5 were utilized in analyses. Thirty-five patients
participated in muscle strength, power and physical functional testing at hospital discharge. One patient’s time
point was missed by researcher, and 5 patients died or
transferred to inpatient hospice before discharge (Additional file 1: Fig. 1).
Muscle ultrasound parameters (n = 41), Fig. 1
mT

Rectus femoris mT at baseline was 0.98 ± 0.3 cm and
decreased at median percent change of 20.1 (IQR 12 to
26%) from ICU day 1 to day 7, statistically significant
change over time (F = 34.89, p = 0.0316). The quadriceps complex mT at baseline was 2.04 ± 0.71 cm and

decreased at median percent change of 14.5 (IQR 7% to
24%) in the first seven days (F = 21.7, p = 0.003). Tibialis
anterior muscle mT was 2.01 ± 0.36 cm at baseline and
decreased at median percent change of 9.1 (IQR 5% to
12%) in the first seven days (F = 28.3, p < 0.001).
CSA

RF muscle CSA at baseline was 2.99 ± 0.99 cm2 and
decreased at median percent change of 18.5% (IQR 11
to 23%) in the first seven days (F = 26.6, p = 0.0253). TA
muscle CSA at baseline was 5.3 ± 0.89 cm2 and decreased
at a median percent change of 8.1 (IQR 5 to 15%) in first
seven days (F = 34.7, p < 0.001).
EI

Rectus femoris EI at baseline was 91 ± 24.9 and increased
at a median percent change of 10.5% (IQR − 5 to 20%) in

Mayer et al. Crit Care

(2020) 24:637

Page 6 of 12

Fig. 1 Change in rectus femoris and tibialis anterior muscle size and quality in first seven days of ICU stay. Panel (a) percent change of muscle
layer thickness; panel (b) percent change of muscle cross-sectional area. (c) Percent change of echo intensity from day 1 to 7. d = days, RF = rectus
femoris muscle; QC = quadricep complex muscles; TA = tibialis anterior muscle

the first seven days (F = 3.28, p = 0.081). Tibialis anterior
EI was 82.7 ± 21.2 at baseline and increased at median
percent change of 15.4 (IQR 7 to 28%) within the first
7 days (F = 6.73, p = 0.002).
Muscle power

Twenty-six patients completed muscle power at ICU
discharge with mean 8.0 ± 2.9 W for 2 lbs resistance and
44.8 ± 22.6 W for 10% of body weight test (Table 2). Muscle power increased from ICU to hospital discharge at a
median percent change of 35% (IQR 15–55%) for 2 lbs
resistance and 27% (IQR 7–48%) for 10% of BW resistance. Muscle power assessment at 2 lbs and 10% of BW
were highly correlated, and therefore, only muscle power
at 10% of BW was utilized in statistical analysis (Table 3).
Relationship between muscle size, quality, power and
strength with physical function at hospital discharge (n = 35)

At ICU discharge 39% (12/31) met diagnosis for ICU-AW
(Table 2). At hospital discharge the mean MRC-ss was
52.4 (5.7) with 25.7% (9/35) meeting criteria for ICUAW. Handgrip strength was 21.7 ± 10 kg and RF muscle strength measured by HHD was 19.8 ± 6.9 kg with
3.6 ± 1.1 s to peak force production (Table 2). Patients
scored an average 5.9 ± 4 on SPPB, with 0.56 ± 0.3 m/s
gait speed and 18.9 ± 14 s to complete 5-times sit-tostand test (Table 2). RF EI on day 1 of ICU admission was
associated with muscle power (rs = − 0.48, p = 0.005),
performance on 5 × STS (rs = 0.462, 0.013), ICU-AW
(rs = 0.337, p = 0.048) and CFS score (0.460, 0.003) at
hospital discharge (Table 3). Muscle power measured at
ICU discharge was significantly related to ICU-AW and
CFS at hospital discharge (Table 3). Muscle power measured at hospital discharge was also significantly related to
age, SOFA at ICU admission, RF CSA, RF EI and measures of strength and function (Table 3).

Prediction modeling

Muscle power measured at ICU discharge, changes in
rectus femoris CSA and EI from day one to seven, and
sex predicted diagnosis of ICU-AW by < 48/60 on MRCss at hospital discharge in 25 patients with complete
data. Muscle power and change in RF EI in first 7 days
of ICU admission were the strongest predictors of ICUAW (Table 4, area under curve = 0.912, Additional file 2:
Fig. 2). Multivariate linear regression demonstrated that
muscle power, age and ICU LOS are significant predictors of muscle 5 × STS performance at hospital discharge in 22 patients completing all measures (Table 4).
Muscle power measured prior to ICU discharge was a
strong independent predictor of sit-to-stand at hospital
discharge.

Discussion
The results of this study demonstrate that muscle ultrasound parameters, specifically RF EI, and lower extremity
muscle power measured in the ICU are significant predictors of physical function at hospital discharge. Assessment of muscle quality by ultrasound and muscle power
in the early course of critical illness, when combined with
age and ICU LOS, may improve classification and prognostication of patients in the ICU at risk for weakness
and physical dysfunction. Identifying the risk of physical impairments in critically ill patients upon admission
or within the first few days in the ICU is important to
improve clinical-decision making for therapeutic interventions. Timely assessment of skeletal muscle promotes
an increased understanding of type and severity of muscle alterations, which may improve prognostication and
lead to a more specific dosage of rehabilitation interventions and/or pharmacologic intervention to mitigate current or continued decline. Furthermore, muscle power
is a novel concept that is rarely assessed in patients with
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Table 2 Muscle ultrasound, strength, power and physical function
Muscle parameter
Ultrasound parameters
TA mT (cm)

Day 1

Day 7

n = 41

n = 41

2.01 (0.36)

1.82 (0.31)

TA CSA ( cmPP2PP)

5.28 (0.89)

4.71 (0.95)

TA EI (0–255)

82.7 (21.2)

96.7 (22.6)

RF mT (cm)

0.98 (0.3)

0.81 (0.27)

RF + VI mT (cm)

2.04 (0.71)

1.77 (0.62)

RF CSA (cmPP2PP)

2.99 (0.99)

2.47 (0.88)

RF EI (0–255)

90.7 (24.9)

99.1 (27.6)

ICU discharge

Hospital discharge

n = 26a

n = 33b

44.8 (22.6)

58.7 (30.6)

Muscle power (W)
2 lbs
10% bodyweight

8.0 (2.89)

9.6 (3.5)

Muscle strength
MRC-ss (0–60)
RF HHD force (kg)
RF HHD RFD (seconds)
TA HHD (kg)
TA HHD RFD (seconds)
Handgrip (kg)
Physical function
SPPB
4-m gait speed (m/s)
5 × STS (seconds)
Balance

6 MWT distance (feet)
CFS

47.1 (7.3) (n = 31)c

d

51.4 (5.7) (n = 35)e

d

3.6 (1.1) (n = 31)f

a

3.7 (1.2) (n = 31)f

19.8 (6.9) (n = 31)f

16.9 (5.3) (n = 24)
d

3.8 (1.1) (n = 24)

15.6 (5.4) (n = 31)f

14.5 (5.2) (n = 24)
d

3.9 (1.2) (n = 24)

21.7 (10.0) (n = 32)g

18.2 (9.1) (n = 26)
4.7 (3.9) (n = 26)a

h

5.9 (4.0) (n = 35)e

0.49 (0.18) (n = 19)

0.56 (0.27) (n = 31)f

1.96 (1.4) (n = 19)h

2.3 (1.2) (n = 31)f

14.8 (5.6) (n = 13)i

265 (182) (n = 26)a
6.1 (1.5) (n = 36)

18.9 (14.5) (n = 28)j
455 (424) (n = 35)e
5.3 (1.7) (n = 36)

TA = tibialis anterior muscle; RF = rectus femoris muscle; CSA = cross-sectional area, mT = muscle layer thickness; EI = echointensity; MRC-ss = Medical Research
Council-sum score; VI = vastus intermedius muscle; HHD = handheld dynamometer; RFD = rate of force development; SPPB = short performance physical battery;
5 × STS = five-times sit-to-stand test; 6 MWT = six-minute walk test; W = watts; CFS = clinical frailty scale

a
Ten patients unable to complete test: 4 patients unable to follow commands/poor cognition; 3 patients had < 3/5 strength; 2 were missed by assessor; and 1 patient
was unable to maintain oxygen saturations > 10% of baseline with simple movement in bed;
b

Three unable to complete: 2 patients with < 3/5 strength and 1 patient unable to complete test: missed by assessor

c

Five patients unable to complete: 4 patients unable to follow commands/poor cognition, 1 patient declined due to pain

d
Twelve patients unable to complete test: patients reported in footnote b plus 2 patients fatigued after initial testing and physically were unable to perform HHD
testing
e

One patient declined due to pain

f

Five patients unable to complete: 2 with < 3/5 strength, 2 deferred to pain/fatigue, 1 patient missed by assessor

g

Four patients unable to complete: 2 with < 3/5 strength, 1 deferred to pain/fatigue, 1 patient missed by assessor

h

Seventeen patients unable to complete test: patients reported in footnote b plus 7 patients unable to stand for balance or walk 4 m without physical assistance

i

Twenty-three patients unable to complete test: patients reported in footnote b plus 13 patients unable to stand from chair in time allotted or without assistance

j

Eight patients unable to complete: 2 with < 3/5 strength, 2 deferred to pain/fatigue, 1 patient missed by assessor, 3 patients could not perform without assistance

and in those patients that have survived critical illness.
The findings of this study suggest that muscle power
should be incorporated in routine practice since power is
a clinically important determinant of physical function.
Muscle power is not a current focus in critical care
rehabilitation, but is a key component of functional
mobility [21] and is important because it accounts for
velocity (time and distance) to perform a task. Muscle

power may present a novel therapeutic target with focus
on an individualized training for patients with deficits.
In older individuals, muscle power has been shown to
decline earlier and at a steeper rate than muscle strength
[52, 53], and therefore power training is a modality purported to mitigate the effects of sarcopenia [54]. Critical
illness muscle wasting certainly has different underlying mechanisms of muscle atrophy when compared to
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Table 3 Correlations between demographics, clinical data and muscle parameters measured in the ICU with physical
function at hospital discharge
Variable

Muscle, Physical Function and Frailty assessed at Hospital Discharge, rs (p = 0.05)
Muscle power (10%
BW)

Age
BMI
CCI
SOFA
ICU LOS

− 0.543 (p = 0.001)

0.096 (p = 0.597)

− 0.006 (p = 0.973)

− 0.353 (p = 0.044)

0.090 (p = 0.618)

Hospital LOS

0.109 (p = 0.545)

RF mT (day 1)

0.248 (p = 0.160)

Delta RF mT

0.112 (p = 0.534)

RF CSA (day 1)
Delta RF CSA
RF EI (day 1)
Delta RF EI

0.379 (p = 0.029)

− 0.159 (p = 0.375)

− 0.480 (p = 0.005)

0.150 (p = 0.406)

PFIT-s*

0.670 (p < 0.001)

MRC-ss*

0.333 (p = 0.090)

Handgrip*

0.712 (p < 0.001)

RF HHD*

0.837 (p < 0.001)

Muscle power (10%
BW)*

0.819 (p < 0.001)

5 × STS
0.822 (p < 0.001)

ICU-AW

4-m gait speed

0.269 (p = 0.118) − 0.629 (p < 0.001)

6 MWT
− 0.596 (p < 0.001)

0.386 (p = 0.042) − 0.285 (p = 0.097) − 0.355 (p = 0.054) − 0.210 (p = 0.219)
0.369 (p = 0.053)

− 0.352 (p = 0.07)

− 0.262 (p = 0.178)

− 0.323 (p = 0.094)

0.137 (p = 0.431) − 0.269 (p = 0.151) − 0.359 (p = 0.032)

CFS
0.554 (p < 0.001)
0.093 (p = 0.567)

0.340 (p = 0.032)

0.400 (p = 0.017)

0.262 (p = 0.162)

0.144 (p = 0.401) − 0.219 (p = 0.174)

0.440 (p = 0.008)

0.433 (p = 0.017)

0.061 (p = 0.722) − 0.026 (p = 0.872)

0.348 (p = 0.041)

− 0.145 (p = 0.461) − 0.308 (p = 0.072)

0.324 (p = 0.081)

0.002 (p = 0.993)

0.028 (p = 0.872)

0.059 (p = 0.732) − 0.152 (p = 0.349)

− 0.178 (p = 0.366) − 0.272 (p = 0.114) − 0.082 (p = 0.667) − 0.079 (p = 0.646)
− 0.230 (p = 0.248) − 0.239 (p = 0.166)

0.131 (p = 0.491)

0.155 (p = 0.339)

0.047 (p = 0.775)

0.211 (p = 0.217) − 0.239 (p = 0.138)

0.123 (p = 0.532) − 0.181 (p = 0.297) − 0.261 (p = 0.163) − 0.105 (p = 0.541) − 0.003 (p = 0.983)
0.462 (p = 0.013)

0.337 (p = 0.048) − 0.324 (p = 0.081) − 0.295 (p = 0.080)

− 0.306 (p = 0.110) − 0.214 (p = 0.218)

0.190 (p = 0.268) − 0.139 (p = 0.392)

0.071 (p = 0.731)

0.429 (p = 0.018) − 0.478 (p = 0.006)

0.122(p = 0.589)

0.443 (p = 0.034) − 0.551 (p = 0.005)

− 0.447 (p = 0.019) − 0.640 (p < 0.001)

0.255 (p = 0.191)

− 0.416 (p = 0.001) − 0.649 (p < 0.001)

0.167 (p = 0.447)

− 0.409 (p = 0.047) − 0.626 (p < 0.001)

− 0.396 (p = 0.076) − 0.597 (p = 0.003)

− 0.386 (p = 0.076) − 0.541 (p = 0.005)

0.460 (p = 0.003)

0.280 (p = 0.134)

0.164 (p = 0.456)

0.648 (p < 0.001)

− 0.763 (p < 0.001)

0.365 (p = 0.073) − 0.489 (p = 0.011)

0.384 (p = 0.058) − 0.622 (p = 0.001)

Ultrasound images analyzed as baseline (day of ICU admission) and change in TA from day 1 to day 7 (delta). Data are displayed as Spearman Rho tests presented as
correlation coefficient with p value
*

Measured at ICU discharge, “Delta” represents the percentage change in muscle mT, CSA and EI from day 1 to day 7

CCI = Charlson comorbidity index; SOFA = sequential organ failure assessment; MRC-ss = Medical Research Council-sum score; RF = rectus femoris muscle;
HHD = handheld dynamometry; SPPB = short performance physical battery; 5 × STS = five time sit-to-stand test; 6 MWT = six-minute walk test; mT = muscle layer
thickness; CSA = cross-sectional; EI = echo-intensity; BW = body weight

Table 4 Multivariate logistic regression predicting ICU-AW at hospital discharge and multivariate linear regression
predicting sit-to-stand performance at hospital discharge
Model p = 0.003 R2 = 0.51, VIF = 1

Odds ratio

Dependent variable: diagnosis of ICU-AW at hospital discharge, n = 25

SE

Power 10% BW in ICU

0.033

0.04

Change in RF CSA days 1 to 7

< 0.001

0.0001

z

− 2.02

− 1.33

[95% CI]

0.044

0.85, 0.99

0.182

8.12e–13, 197.7

Change in RF EI days 1 to 7

4.40

0.0003

0.074

5.76e−12, 3.36

Male

0.53

1.25

1.56

0.787

0.005, 54.3

Model p = 0.04, R2 = 0.55, VIF 1.11

β-coefficient

SE

t

P >|t|

[95% CI]

Dependent variable: performance on 5 × STS test at hospital discharge, n = 22
Power 10% BW in ICU

− 0.282

0.124

− 1.78

P >|z|

− 2.26

0.036

− 0.543, − 0.020

Age

0.534

0.173

3.09

0.006

0.171, 0.897

ICU LOS

− 0.091

0.033

− 2.76

0.013

− 0.161, − 0.0217

BW = bodyweight; RF = rectus femoris; CSA = cross-sectional area, EI = echo-intensity; ICU = intensive care unit; LOS = length of stay

mechanisms of age-related muscle mass loss. The concepts of muscle power training, however, may be beneficial in both populations. Additionally, more than
half of ICU admissions in the USA are older individuals

(> 65 years of age) [55] and thus suggest muscle power is
an important construct in muscle and physical dysfunction for those critically ill. The ability to generate force,
quickly to overcome gravity to stand from seated position
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requires lower-extremity muscle power [56]. Previous
data suggest that older patients and those with longer
mechanical ventilation will have delayed time to achieve
independence with sit-to-stand transfer [57]. Thus,
5 × STS was selected as the primary physical function
outcome of interest since it has strong construct validity
with muscle strength and power, an important measure
of functional mobility [58, 59]. Changes in muscle power
may be explained by a selective decrease in type-II muscle fibers, which are most important for power production. Data from muscle biopsies demonstrate that type-II
fibers have smaller CSA and potentially decrease at more
predominant rate than type-I fibers in patients requiring
mechanical ventilation [60, 61]. Data from muscle power
assessment in this study had moderate to strong correlations with rectus femoris muscle size, muscle EI, strength
and physical function. Rectus femoris muscle has a high
composition of type IIA and IIX muscle fibers [62] which
supports the relationship between muscle power and rectus femoris muscle size and quality in this study. Muscle
power increased from ICU to hospital discharge, which
may suggest time points in the ICU, may be influenced by
limited voluntary muscle contraction when patients are
acutely ill. Muscle power measured at hospital discharge
in this cohort was significantly reduced compared to previously reported data from healthy, age-matched controls (reductions up to 47%) [41]. Muscle power should
be explored in future studies to understand long-term
recovery.
Results of the current study confirm the rapid and significant deterioration in skeletal muscle size and quality
in patients admitted to the ICU for critical illness that
have been reported in prior published work [1, 25, 63,
64]. We demonstrated decrease in RF muscle CSA of 19%
in first week of critical illness, slightly higher than prior
data ranging from decreases of 12.5% to 17% [1, 25, 65].
It should be noted that baseline RF muscle size (mT and
CSA) was lower when compared to previous studies [25,
64]. This may be explained by differences in landmarking,
variability in sonographer compression technique and,
more likely, differences in study populations. Specifically,
the inclusion of patients in the cardiothoracic ICU with
heart or lung failure with potential for chronic wasting
and frailty may explain part of the differences in baseline
rectus femoris muscle size. Differences in techniques and
heterogeneous populations confirm the need to develop
standardized approaches when performing muscle ultrasound in the ICU [27]. EI, a marker of muscle quality
[66], increased across these same time points by 10.5%,
which is similar to prior published data (+ 9.6%) [25].
These changes are purported to be clinically meaningful
deteriorations in the muscle structure potentially related
to myofiber necrosis [66, 67].
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Muscle ultrasound is a non-invasive and relatively
inexpensive tool that can be implemented early during critical illness to potentially expedite classification
of muscle mass and quality. Early diagnosis and classification of patients at risk for physical impairments may
improve outcomes by promoting earlier allocation or
greater intensity (number of visits) of physical rehabilitation. Current diagnosis of ICU-AW is typically delayed
until the patient can volitionally engage in the MRCss [35, 68]. Therefore, ultrasound used early in the time
course of critical illness when patients are not yet able to
volitionally engage may improve assessment of muscle
dysfunction. Data from this study demonstrate that deterioration in rectus femoris muscle quality is moderately
and significantly correlated with ICU-AW, physical function and clinical frailty scale at hospital discharge. Therefore, this study provides preliminary data to suggest that
quantification of muscle quality with ultrasound imaging
can improve classification of patients at risk for ICUAW and physical impairments. The findings may also
suggest that muscle size may not be the best predictor
of outcomes, specifically ICU-AW. Muscle mass or size
has previously been shown not to correlate with muscle
strength [69, 70], potentially demonstrating that atrophy
may not be the primary culprit of ICU-AW. These data,
interpreted with caution, may support that deteriorations
in muscle quality and muscle power may partially explain
development of ICU-AW.
The primary limitation of this study is the small sample
size limiting the strength of correlations and the strength
of the modeling or prediction analyses. Multivariate
logistic and linear regression were performed as exploratory analyses and should be interpreted with caution due
to the study being under-powered. The study was not
powered to conduct group analyses and such we focused
on the descriptive data and correlations. Additional
exploratory analyses were not performed in this study
as the primary aim was focused on early muscle assessment to predict physical function at hospital discharge. A
secondary limitation is some missing data due to assessor
availability or the patient unable to complete tests due to
pain, lack of cognitive function or change in care to hospice or comfort care. Finally, research conducted in the
ICU is limited due to timing; it is likely that patients have
suffered changes in muscle and physical function long
before admission to the ICU which makes establishing a
baseline nearly impossible.

Conclusion
In this study we showed that changes in muscle quality
and power assessed in the ICU are significantly related
to physical function in patients with critical illness.
Muscle power could be an important clinical measure

Mayer et al. Crit Care

(2020) 24:637

to be considered in the assessment of patients with and
those patients that have survived critical illness.
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